Autoimmune Diseases and Cannabis Part 2 – Fibromyalgia
In the second installment of this 10-part series, we take an in-depth look at utilizing cannabinoid therapies for 1 of the most common autoimmune diseases, Fibromyalgia. Fibromyalgia, which is sometimes called fibrositis like other autoimmune diseases, has no cure. This AD also has no known definitive cause. It is estimated that Fibromyalgia affects 2% of the adult population in America, equaling roughly 4 million individuals. This autoimmune disease is characterized by widespread tenderness and pain throughout the muscles and bones. It is commonly accompanied by other symptoms such as sleep pattern disturbances, altered mood, changes in memory function, and fatigue. Research to date shows excellent potential in cannabinoid therapies as a treatment for many of the symptoms associated with Fibromyalgia. A study published in 2019 showed that cannabinoid therapies provided 81% of study patients with at least moderate improvement in their fibromyalgia-related symptoms. Additionally, a large proportion of participants were able to reduce or eliminate their opioid intake entirely while also drastically reducing their pain. Check out this article to learn more about how cannabinoid therapies may help those living with Fibromyalgia.